发明名称 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor
摘要 The invention provides isolated nucleic acids molecules, designated 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 or 33751 gene has been introduced or disrupted. The invention still further provides isolated 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 or 33751 proteins, fusion proteins, antigenic peptides and anti-18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 or 33751 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
申请公布号 US2009226449(A1) 申请公布日期 2009.09.10
申请号 US20090381748 申请日期 2009.03.16
申请人 MILLENNIUM PHARMACEUTICALS, INC. 发明人 GLUCKSMANN MARIA A.;CURTIS RORY A.J.;LORA JOSE M.;GALVIN KATHERINE M.;SILOS-SANTIAGO INMACULADA
分类号 A61K39/395;A61K31/7105;A61K38/17;A61K38/48;A61P35/00;A61P43/00;C07H21/04;C07K14/47;C07K16/18;C12N5/06;C12N5/10;C12N15/12;C12P21/02;C12Q1/68;G01N33/566 主分类号 A61K39/395
代理机构 代理人
主权项
地址